From the Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
Clin Nucl Med. 2019 Apr;44(4):337-338. doi: 10.1097/RLU.0000000000002478.
A 76-year-old man presented with recently diagnosed prostate adenocarcinoma, Gleason score of 4 + 4, and a Super bone scan with concurrent PSA of 1.7 ng/mL. Approximately 3.5 months later, an F-fluciclovine PET/CT was performed despite of a decreased PSA of 0.3 ng/mL. A Superscan fluciclovine PET/CT was identified, and bone metastasis were later confirmed at biopsy.
一位 76 岁男性被诊断为前列腺腺癌，Gleason 评分为 4+4，超级骨扫描同时伴有 PSA 为 1.7ng/mL。大约 3.5 个月后，尽管 PSA 降至 0.3ng/mL，仍进行了 F-氟代脱氧葡萄糖 PET/CT 检查。发现 Superscan 氟代脱氧葡萄糖 PET/CT，随后经活检证实存在骨转移。
